The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Cernevit, Powder for Solution for Injection or Infusion



Baxter Holding B.V.PA2299/019/001

Main Information

Trade NameCernevit, Powder for Solution for Injection or Infusion
Active SubstancesRetinol palmitate
Cholecalciferol
Dl-a-tocopherol
Ascorbic acid
Cocarboxylase tetrahydrate
Riboflavin sodium phosphate
Pyridoxine hydrochloride
Cyanocobalamin
Folic acid
Dexpanthenol
D-biotin
Nicotinamide
Dosage FormPowder for solution for injection/infusion
Licence HolderBaxter Holding B.V.
Licence NumberPA2299/019/001

Group Information

ATC CodeA11BA Multivitamins, plain

Status

License statusAuthorised
Licence Issued04/01/1993
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back